× False Dawns and New Horizons in Patient Safety Research and Practice

×

The Urgency to Mitigate the Spread of Hepatitis C in Pakistan Through Blood Transfusion Reform

× Validation of Instruments for Assessing Drug Safety Management During the Conduction of Clinical Trials

× It Ain’t What You Do (But the Way That You Do It): Will Safety II Transform the Way We Do Patient Safety? Comment on “False Dawns and New Horizons in Patient Safety Research and Practice”

× A Safety-II Perspective on Organisational Learning in Healthcare Organisations Comment on “False Dawns and New Horizons in Patient Safety Research and Practice”

× Safety I to Safety II: A Paradigm Shift or More Work as Imagined? Comment on “False Dawns and New Horizons in Patient Safety Research and Practice”

× Disturbing the Doxa of Patient Safety Comment on “False Dawns and New Horizons in Patient Safety Research and Practice”

× Medication Errors Associated With Adverse Drug Reactions in Iran (2015-2017): A P-Method Approach 

× First Nations Peoples’ Participation in the Development of Population-Wide Food and Nutrition Policy in Australia: A Political Economy and Cultural Safety Analysis

× Understanding the Prevalence and Associated Factors of Behavioral Intention of COVID-19 Vaccination Under Specific Scenarios Combining Effectiveness, Safety, and Cost in the Hong Kong Chinese General Population

× What Lies Behind Successful Regulation? A Qualitative Evaluation of Pilot Implementation of Kenya’s Health Facility Inspection Reforms

× A Gateway Framework to Guide Major Health System Changes Comment on “‘Attending to History’ in Major System Change in Healthcare in England: Specialist Cancer Surgery Service Reconfiguration”